Published 11 November 2019 Carl-Johan Fraenkel. Photo: Tove Smeds Contagion spreads in various ways, with airborne viruses being especially difficult to protect oneself against. Norovirus, or the winter vomiting bug as it is sometimes known, is just such a virus. Carl-Johan Fraenkel, infectious disease and healthcare hygiene specialist, is currently defending his thesis at Lund University, looking

https://www.medicine.lu.se/article/researchers-track-spread-norovirus-hospitals - 2025-04-01

Published 11 November 2019 For a decade now, the Rehabilitation Medicine research group’s work on spinal cord injuries (SCI’s) has had a far-reaching impact. In many areas, this is research at the global cutting edge; not least, in terms of following the same group of individuals as they live – and age – with spinal cord injuries. Research group leader Jan Lexell is preparing to flex the group’s a

https://www.medicine.lu.se/article/lund-research-spinal-cord-injuries-continues-have-global-impact - 2025-04-01

Published 12 November 2019 Joan Yuan, research team leader at the Department of Laboratory Medicine. Photo: Åsa Hansdotter Directly after birth, the immune system completes production of a subtype of antibody-producing immune cells, B-1, that are to last for a lifetime. No more B1-cells are formed after that point. However, these cells are self-reactive – they produce not only antibodies against f

https://www.medicine.lu.se/article/how-self-reactive-immune-cells-are-allowed-develop - 2025-04-01

Published 12 November 2019 Rebecca Warfvinge. Photo: Åsa Hansdotter. Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the patient will re

https://www.medicine.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2025-04-01

Published 9 December 2019 When then medical student Jonatan Wistrand met a patient who was seriously ill with cancer a few years ago he was extremely moved. On November 29 he defended his doctoral thesis at Lund University with his thesis “The doctor as the patient – documentary and literary statements during the 20th and 21st century”. “I did my training in medical school but worked temporarily d

https://www.medicine.lu.se/article/situation-conflict-when-doctor-becomes-patient - 2025-04-01

Published 9 December 2019 Mobile apps can help patients with neurological disorders manage their symptoms better and stimulate people into having a healthier lifestyle. This is indicated by interdisciplinary research conducted at the research centre CASE at Lund University, which has been published in the scientific journal Disability and Rehabilitation: Assistive Technology. “The results are sign

https://www.medicine.lu.se/article/improved-symptom-management-and-healthier-lifestyle-help-apps - 2025-04-01

Published 9 December 2019 Einar Smith is being awarded the Swedish Savings Bank Foundation scholarship for his thesis. A prospective study which demonstrates that the metabolite ergothioneine, independent of other risk factors, can be linked to a reduced risk of cardiovascular disease and premature death. The study is published in BMJ Heart. Einar Smith is being awarded the Swedish Savings Bank Fo

https://www.medicine.lu.se/article/connection-between-markers-healthy-diet-and-reduced-risk-cardiovascular-disease-resulted-scholarship - 2025-04-01

Published 9 December 2019 Para-athletics is growing in strength worldwide. However, behind the Paralympics that we watch on TV from our sofas there are greater challenges than those related to results. A new thesis from Lund University demonstrates how Paralympic athletes run the risk of sustaining injuries as a result of strict training as well as illnesses caused by their disability. To ensure t

https://www.medicine.lu.se/article/paralympic-athletes-double-struggle-against-injuries-and-diseases - 2025-04-01

Published 11 December 2019 The European Research Council today announced the winners of its latest Consolidator Grant competition: 301 top scientists and scholars across Europe. Funding for these researchers, part of the Horizon 2020 research and innovation programme, is worth in total EUR 600 million. Filipe Pereira at Lund University in Sweden is one of the 89 selected researchers, and will be a

https://www.medicine.lu.se/article/prestigious-erc-grant-innovative-immunotherapy-research - 2025-04-01

Published 13 December 2019 Zaal Kokaia, Professor within the Department of Clinical Sciences and Director of Lund Stem Cell Center, has been awarded Georgia’s most prestigious scientific prize - the National Prize in Science. The award comes as a result of his outstanding contribution to world class scientific research and was presented to Prof. Kokaia at a ceremony in the Presidential Palace, Tbi

https://www.medicine.lu.se/article/prestigious-scientific-prize-awarded-director-lund-stem-cell-center - 2025-04-01

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 18 December 2019 Prof. Åsa Petersén, Dep. of Experimental Medical Science, Astri Arnesen, President of The European Huntington Assocation and Patrick Weydt, the European Huntington Disease Network at the Nordic Huntington Disease Research Meeting in Lund. A few weeks ago The Huntington Disease Center in Lund, Swede

https://www.medicine.lu.se/article/european-huntington-heights-met-lund-summit - 2025-04-01

Published 9 January 2020 Anna Häger Glenngård and Sixten Borg. (Photo: Louise Larsson) The risk of experiencing financial difficulties due to medical care costs is relatively small in Sweden. This is revealed in a recent report from the World Health Organization, where researchers from Lund University have investigated the extent to which Swedish households are financially affected by using the he

https://www.medicine.lu.se/article/who-report-healthcare-sweden-among-most-affordable-europe - 2025-04-01

Published 9 January 2020 Merab Kokaia and My Andersson (Photo: Tove Smeds) Researchers at Lund University in Sweden have used a neuropeptide to successfully reduce seizure-like activity in tissue from patients with drug-resistant epilepsy. One challenge facing researchers who study brain diseases is that for understandable reasons it is difficult to obtain human brain tissue for experiments. For t

https://www.medicine.lu.se/article/peptide-reduced-epileptic-seizures-human-brain-tissue - 2025-04-01

Published 9 January 2020 Madelene Å Andersson, Sven Kjellström, Jitka Petrlova, Artur Schmidtchen, Ann-Charlotte Strömdahl, Manoj Puthia. (Photo: Olle Dahlbäck) Researchers at Lund University in Sweden have developed a new hydrogel based on the body’s natural peptide defense. It has been shown to prevent and treat infections in wounds. The formulation kills multi-resistant bacteria, something that

https://www.medicine.lu.se/article/next-generation-wound-gel-treats-and-prevents-infections - 2025-04-01

By tove [dot] gilvad [at] med [dot] lu [dot] se (Tove Gilvad) - published 23 January 2020 European complementologists have joined forces and created CORVOS. A highly coordinated and innovative research and training program for early stage researchers in immunology and infectious diseases. Lund University is a part of the initiative. Anna Blom, Professor at Lund University, participating in the COR

https://www.medicine.lu.se/article/corvos-european-joint-doctorate-programme-immunology - 2025-04-01

Published 29 January 2020 Immunofluorescence analysis of a melanoma tumor showing that B cells in B cell clusters express CXCR5, a marker for tertiary lymphoid structures. (Source: Göran Jönsson) Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The

https://www.medicine.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2025-04-01

Published 3 February 2020 In a major study of hereditary breast cancer, a global network of researchers (including some from Lund University) has identified over 350 faults in DNA that increase an individual’s risk of developing the disease. The researchers believe that these faults can affect as many as 190 genes. Published in Nature Genetics, a scientific journal, the results are said to be the

https://www.medicine.lu.se/article/major-study-gives-most-comprehensive-map-breast-cancer-risk - 2025-04-01

Published 4 February 2020 Up to 45 per cent of all deaths in industrialised countries are caused by fibrotic diseases. Through boundary-crossing research and the high-tech MAX IV laboratory in Lund it is possible to increase the knowledge of fibrosis – bringing a cure closer. ”Fibrosis is a form of scarring that can affect all types of damaged organs and tissues in the body. When this process take

https://www.medicine.lu.se/article/high-tech-collaboration-supports-fibrosis-research - 2025-04-01

Published 6 February 2020 Within the framework of an international study, Lund University and Skåne University Hospital have started treating patients with hemophilia with gene therapy, something that began in January this year. The hope is that the new treatment will significantly simplify everyday life for those with severe hemophilia. Hemophilia is a genetic disease where the body does not prod

https://www.medicine.lu.se/article/hemophilia-being-treated-gene-therapy - 2025-04-01

Published 6 February 2020 The Leif C. Groop Award for Outstanding Diabetes Research has been awarded to Niels Grarup of the Novo Nordisk Foundation Centre for Basic Metabolic Research at the University of Copenhagen. His research has shown that there is a genetic explanation for the increase in type 2 diabetes in Greenland. The prize, worth SEK 100 000, is donated by the pharmaceutical company Nov

https://www.medicine.lu.se/article/award-research-increased-risk-type-2-diabetes-greenland - 2025-04-01